ONE-STOP-SITE
Live / Registered — Registered (as of 24 Aug 2021)
What this means for you
Registered since 24 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79295569
- Registration number
- 6458312
- Mark type
- Stylized text
- Filed
- 02 Jun 2020
- Published for opposition
- 08 Jun 2021
- Registered
- 24 Aug 2021
- Attorney of record
- R. Peter Spies
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
- Class 005 — Pharmaceuticals: Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; pharmaceutical active ingredients, namely, sold as a component ingredient of pharmaceutical preparations, and pharmaceutical preparations and compounds, all of the foregoing for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
- Class 042 — Scientific and technological services: Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research and development services in the pharmaceutical field; research and development services in the field of pharmaceuticals, chemical preparations, vaccines, medicines, antibodies, new products in the medical field
Owner
Prosecution history
- 07 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 May 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Feb 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 04 Feb 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 03 Feb 2022 — FINAL DISPOSITION PROCESSED
- 24 Nov 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 24 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jun 2021 — PUBLISHED FOR OPPOSITION
- 19 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 May 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED